Filing Details

Accession Number:
0001181431-14-023657
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-11 17:37:22
Reporting Period:
2014-06-10
Filing Date:
2014-06-11
Accepted Time:
2014-06-11 17:37:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1076979 D Michael Kishbauch C/O Achillion Pharmaceuticals
300 George Street
New Haven CT 06511
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-10 371,937 $3.10 371,937 No 4 M Direct
Common Stock Disposition 2014-06-10 371,937 $7.75 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2014-06-10 371,937 $0.00 371,937 $3.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-16 No 4 M Direct
Footnotes
  1. This option was granted on December 16, 2010 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter through September 18, 2013, Mr. Kishbauch's last day of employment with the Company.